IR News

2024.04.17IR

Notice on the NHI Drug Price Standard Listing and Launch Schedule of Zokinvy for the Treatment of Progeria

2024.04.12IR

Notice Regarding Eiger BioPharmaceuticals, Inc.

2024.03.15IR

Notice of Business Restructuring at Consolidated Subsidiary

2024.03.14IR

Notice of Conclusion of License Agreement and Revision of Consolidated Financial Results Forecast for FY2024

2024.02.22IR

FY2023 Financial Results Materials （correction）

【 Corporate Brochure 】

Introduction of company overview and our business

PDF